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Kathryn B. Garber1,*Disruption of Golgi Leads to a Skeletal Dysplasia
How does a Golgi-assembly protein with widespread
expression lead to what appears to be a tissue-speciﬁc
phenotype? This question arose during the research of
Smits et al., who used a forward genetic approach to ﬁnd
the gene responsible for a neonatal lethal skeletal dysplasia
in mice. Loss-of-function mutations in the human homo-
log of this gene, TRIP11, lead to a highly similar pheno-
type—Achondrogenesis type 1A—which is a neonatal
lethal disorder that includes a lack of vertebral-body and
skull ossiﬁcation. The Trip11 mutation ablates expression
of the golgin protein GMAP-210, a protein known to
have a role in assembly and maintenance of the Golgi
apparatus. What Smits et al. discover is that the Golgi
structure is disrupted in some, but not all, cell types in
these mutant mice. At a protein level, there is also speci-
ﬁcity to GMAP-210 activity; Trip11 mutations disrupt
glycosylation and transport of certain proteins expressed
in chondrocytes. The particular sensitivity of chondrocytes
to this defect leads to abnormal differentiation of these
cells and increased apoptosis. Why are these cells particu-
larly sensitive to this defect? Perhaps because they put
more of a demand on the Golgi apparatus for secretion
of proteins to the extracellular matrix and perhaps as
a result of the speciﬁc proteins that GMAP-210 selects as
cargo in these cells.
Smits et al. (2010). N. Engl. J. Med. 362, 206–216.
Histone Modiﬁcations Regulate Alternative Splicing
Different cell types sometimes splice identical transcripts
in different ways, a property that increases the diversity
of gene products in the body. We don’t have a full under-
standing of the mechanism by which each cell type recog-
nizes the exons that should be included in an alternatively
spliced transcript, although alternative splicing is inﬂu-
enced by the elongation rate of RNA polymerase II and
by chromatin remodelers. Luco et al. propose a much
more speciﬁc alternative-splicing model in which epige-
netic modiﬁcations are a cue for alternative splicing.
They base this model on their ﬁnding that local histone
modiﬁcations inﬂuence the recruitment of splice regulator
proteins, which themselves determine splicing. Luco et al.
used FGFR2 as a system to study alternative splicing
because it includes two mutually exclusive exons that are
chosen in a tissue-speciﬁc manner. Through comparisons
of two cell types that use different FGFR2 exons, they iden-1Department of Human Genetics, Emory University School of Medicine, Atlan
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type compared to the other and that correlated with exon
selection. For example, H3-K36me3 at FGFR2was enriched
in cells that repress use of exonIIIb, and inclusion of this
exon in spliced transcripts could be modulated by regula-
tion of the expression levels of H3-K36 methyltransferases.
Additional experiments by Luco et al. support a model in
which the chromatin binding protein MRG15 binds to
H3-K36me3, and this in turn recruits the splice regulator
PTB to FGFR2. The same histone modiﬁcations and
binding proteins inﬂuence alternative splicing at other
genes but are not the universal regulators of splicing. How-
ever, it seems plausible that the same type of system could
be used for regulating splicing at other genes, albeit with
different histone modiﬁcations recognized by another
chromatin binding protein.
Luco et al. (2010). Sciencexpress. Published online February
2, 2010. 10.1126/science.1184208.
Hsp70: Two for the Price of One
How’s this for translational research taking an unexpected
direction? Kirkegaard et al. were interested in the way in
which heat shock protein 70 (Hsp70) protects cells from
stress-induced death by blocking lysosome permeabiliza-
tion. Because this can promote survival of cancer cells,
an understanding of this function of Hsp70 has clinical
relevance. Although Hsps are classically thought to help
proteins fold, some are also known to interact with cellular
membranes. Kirkegaard et al. used an osteosarcoma cell
line to show that under the acidic conditions of the
lysosome, Hsp70 mediates its protective effect via an
interaction with the anionic lipid bis(monoacylglycero)
phosphate (BMP). BMP interacts with and stimulates the
acid sphingomyelinase (ASM), whose sphingomyelin-
hydrolyzing activity is required for the stabilizing effect
of Hsp70. Here’s where the unexpected translational appli-
cation of the research comes in. In what cells is ASM
activity defective? Those from people with Niemann-Pick
disease (NPD). In fact, these cells turn out to be particularly
sensitive to stress-induced lysosomal permeabilization,
but this effect can be rescued by recombinant Hsp70.
More importantly for NPD, addition of Hsp70 normalizes
lysosomal volume, which in untreated cells is markedly
increased as a result of sphingomyelin storage. Thus,
although they started out studying a target for cancer ther-
apies, Kirkegaard et al. uncovered a potential therapeuticta, GA 30322, USA
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approach for a lysosomal-storage disorder. That adds up to
two potential translational applications for the price of one
basic research study.
Kirkegaard et al. (2010). Nature 463, 549–553. 10.1038/
nature08710.
Two Hit Models: Not Just for Cancer Anymore
Our ability to ﬁnd copy-number changes in the human
genome has gotten so good over the past few years that
deﬁning new microdeletion and microduplication syn-
dromes seems to be pretty clear if you’ve got a good patient
population and you’re observant. The work of Girirajan
et al. suggests that things might not always be so straight-
forward. They report a new recurrent microdeletion at
chromosome 16p12.1 that is associated with develop-
mental delay but has a variable phenotype that can include
congenital heart defects, seizure disorders, growth abnor-
malities, and psychiatric disorders. Further evaluation of
these individuals found that many of them had an addi-
tional large CNV at a different genomic location. In fact,
the rate of second large hits in probands with the
16p12.1 deletion was six times that in a set of normal
control individuals with at least one large CNV. Although
the authors believe that the 16p12.1 microdeletion is an
independent risk factor for intellectual disability and
developmental delay, they propose a two-hit model for
the phenotype whereby a second CNV, a mutation in
a related gene, or an environmental exposure inﬂuences
the severity of the phenotype. The second-hit model
is not unique to the16p12.1 microdeletion-associated300 The American Journal of Human Genetics 86, 299–301, March 1phenotypes; the authors believe that it might play a role
in the expression of other genomic disorders with vari-
ability penetrance or expressivity. Such disorders might
include the chromosome 1q21.1 microdeletion syndrome,
which is also frequently associated with a second large
CNV.
Girirajan et al. (2010). Nature Genetics. Published February
14, 2010. 10.1038/ng.534.Guilt by Association with FMRP
Loss of the Fragile X Mental Retardation Protein (FMRP)
leads to intellectual disability, a key feature of the fragile
X syndrome. On a functional level, FMRP interacts with
microRNAs (miRNAs) and regulates protein synthesis of
speciﬁc mRNAs, and on a cellular level, loss of FMRP func-
tion causes synaptic abnormalities and alters synaptic plas-
ticity. A gap exists in our ability to connect these observa-
tions, but Edbauer et al. ﬁgured that the identiﬁcation of
FMRP-associated miRNAs could close it. They identiﬁed
miR-125b and miR-132 as two FMRP-associated miRNAs
that inﬂuence dendritic-spine structure. A predicted target
of miR-125b regulation is NR2A, the regulatory subunit of
NMDA receptors. Indeed, in cultured neurons, miR-125b
and FMRP work together to negatively regulate NR2A
through its 30 untranslated region, and manipulation of
miR-125b levels inﬂuences the synaptic morphology and
function of NMDAR channels.
Edbauer et al. (2010). Neuron 65, 373–384. 10.1016/
j.neuron.2010.01.005.This Month in Our Sister JournalsAn Approach to Population Screening for Fragile
X Syndrome
Although the population frequency of fragile X syndrome
pre- and full mutations is high enough to support the idea
of population-based Fragile X screening, technical limita-
tions have hampered the consideration of this idea. The
basic problem is this: unless multiple genotyping tech-
niques are used, the size range of the FMR1 CGG repeat
and its tendency to form secondary structure in a PCR reac-
tion can lead to false negative results, particularly in
females. Hantash et al. developed a PCR-based screening
procedure that requires a single tube. The method is based
on triplet-primed PCR with a set of primers that includes
a CGG repeat. To reduce the formation of secondary struc-
ture by single-stranded stretches of DNA that include this
repeat, they use the nucleotide analog 7-deaza-2deoxyGTP,
which reduces the potential hydrogen bonds that can form
between the G’s and C’s and within higher-order struc-
tures. The reaction products are screened by capillary elec-
trophoresis to allow qualitative identiﬁcation of premuta-
tion and full mutation carriers from a population. Fora set of more than 1300 samples, the results of this new
method were fully concordant with the results from this
group’s currently used and more labor-intensive platform
for Fragile X analysis. This screen is not diagnostic; follow-
up will be required to accurately determine the CGG repeat
size and methylation status of positive samples. However,
compared to other screening methodologies, this method
reduces the number of follow-up analyses and has
increased sensitivity for full mutations and in mosaic
samples. Now that this and other methods are getting
around the tricky technical barriers to population
screening, we have to face the perhaps even trickier social
and ethical issues surrounding Fragile X screening.
Hantash et al. (2010). Genetics in Medicine. 10.1097/
GIM0b013e3181d0d40e.
Using both Linkage and Linkage Disequilibrium
Information for Genotype Phasing
When you genotype a diploid organism, you get two
alleles for each autosomal locus, but the raw data don’t
tell you which allele is on which chromosome of the2, 2010
pair. Determining the likely combinations of alleles on
a chromosome—in other words, phasing the genotypes—
can be accomplished with population-based information
or family-based information. Druet and Georges have
developed a method for phasing high-density SNP geno-
types that uses both types of data, and their approach
improves the accuracy of phase reconstruction and theThe Ameriimputation of missing genotypes. The authors test their
approach on real and simulated datasets of dairy cattle.
The reconstructed haplotypes can be clustered into related
chromosomes that can be used for ﬁne mapping of quan-
titative trait loci.
Druet and Georges. (2010). Genetics. Published online
February 14, 2010. 10.1534/genetics.109.108431.can Journal of Human Genetics 86, 299–301, March 12, 2010 301
